Neurotoxicity clinical trials at University of California Health
2 in progress, 1 open to eligible people
Cannabis Effects on Antiretroviral Therapy Pharmacokinetics and Neurotoxicity
open to eligible people ages 18 years and up
This study will address whether cannabis affects antiretroviral therapy (ART) drug concentrations, mood, and thinking. The project will have two phases. Phase 1 is an observational study, in which 120 people will be assessed to evaluate the effects…
at UCSD
Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma
Sorry, in progress, not accepting new patients
RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. Drugs used in…
at UC Irvine UCSD
Our lead scientists for Neurotoxicity research studies include Scott Letendre, MD.
Last updated: